The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Open accessAbstract
Hurting the virus by targeting the host: Many host proteins play a role in the life cycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and some are required for viral replication and translation. There are efforts toward finding drugs that target viral proteins, but a complementary approach is to target these required host proteins. White et al. explored the antiviral activity of the cyclic depsipeptide drug plitidepsin, which targets the hosts cell's translational machinery (see the Perspective by Wong and Damania). The authors show that in cells, the drug is substantially more potent than remdesivir against SARS-CoV-2, with limited cellular toxicity. Prophylactic treatment protected mice against SARS-CoV-2 infection, so further investigation of plitidepsin as a therapeutic is warranted. Science , this issue p. 926 ; see also p. 884
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Self-citationSARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023184 · Cited by 2,745
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Spinner, C. D., Gottlieb, R. L., Criner, G. J., Arribas López, J. R., Cattelan, A. M., Soriano Viladomiu, A., Ogbuagu, O., Malhotra, P., Mullane, K. M., Castagna, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.16349 · Cited by 1,211
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C. (2020) · Nature · doi:10.1038/s41586-020-2332-7 · Cited by 1,010
Winkler, E. S., Bailey, A. L., Kafai, N. M., Nair, S., McCune, B. T., Yu, J., Fox, J. M., Chen, R. E., Earnest, J. T., Keeler, S. P., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0778-2 · Cited by 901
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Menachery, V. D., Yount, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X.-Y., Donaldson, E. F., et al. (2015) · Nature Medicine · doi:10.1038/nm.3985 · Cited by 901
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Ianevski, A., Giri, A. K., & Aittokallio, T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa216 · Cited by 873
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
Zhang, Y.-Z., & Holmes, E. C. (2020) · Cell · doi:10.1016/j.cell.2020.03.035 · Cited by 818
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management
Rajkumar, S. V. (2020) · American Journal of Hematology · doi:10.1002/ajh.25791 · Cited by 789
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Riva, L., Yuan, S., Yin, X., Martin-Sancho, L., Matsunaga, N., Pache, L., Burgstaller-Muehlbacher, S., De Jesus, P. D., Teriete, P., Hull, M. V., et al. (2020) · Nature · doi:10.1038/s41586-020-2577-1 · Cited by 760
Self-citationComparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
Gordon, D. E., Hiatt, J., Bouhaddou, M., Rezelj, V. V., Ulferts, S., Braberg, H., Jureka, A. S., Obernier, K., Guo, J. Z., Batra, J., et al. (2020) · Science · doi:10.1126/science.abe9403 · Cited by 747
Self-citationA Contemporary View of Coronavirus Transcription
Sawicki, S. G., Sawicki, D. L., & Siddell, S. G. (2007) · Journal of Virology · doi:10.1128/jvi.01358-06 · Cited by 598
SARS-like WIV1-CoV poised for human emergence
Menachery, V. D., Yount, B. L., Sims, A. C., Debbink, K., Agnihothram, S. S., Gralinski, L. E., Graham, R. L., Scobey, T., Plante, J. A., Royal, S. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517719113 · Cited by 418
Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
Anthony, S. J., Gilardi, K., Menachery, V. D., Goldstein, T., Ssebide, B., Mbabazi, R., Navarrete-Macias, I., Liang, E., Wells, H., Hicks, A., et al. (2017) · mBio · doi:10.1128/mbio.00373-17 · Cited by 357
Bat origin of human coronaviruses
Hu, B., Ge, X., Wang, L.-F., & Shi, Z. (2015) · Virology Journal · doi:10.1186/s12985-015-0422-1 · Cited by 344
Liang, Y., Wang, M.-L., Chien, C.-S., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y.-H., Lin, Y.-T., Chen, Y.-J., Chang, P.-C., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01022 · Cited by 339
The Middle East Respiratory Syndrome Coronavirus ( MERS - COV )
Jahan, F., & Al Maqbali, A. A. (2015) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2015.92625 · Cited by 334
Molecular diversity of coronaviruses in bats
Woo, P. C. Y., Lau, S. K. P., Li, K. S. M., Poon, R. W. S., Wong, B. H. L., Tsoi, H.-W., Yip, B. C. K., Huang, Y., Chan, K.-H., & Yuen, K.-Y. (2006) · Virology · doi:10.1016/j.virol.2006.02.041 · Cited by 322
Molecular identification and phylogenetic analysis of baculoviruses from Lepidoptera
Jehle, J. A., Lange, M., Wang, H., Hu, Z., Wang, Y., & Hauschild, R. (2006) · Virology · doi:10.1016/j.virol.2005.10.032 · Cited by 299
Shah, M. H., Binkley, P., Chan, K., Xiao, J., Arbogast, D., Collamore, M., Farra, Y., Young, D., & Grever, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2689 · Cited by 241
Piekarz, R. L., Frye, A. R., Wright, J. J., Steinberg, S. M., Liewehr, D. J., Rosing, D. R., Sachdev, V., Fojo, T., & Bates, S. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2095 · Cited by 232
Human iPS cell–derived alveolar epithelium repopulates lung extracellular matrix
Ghaedi, M., Calle, E. A., Mendez, J. J., Gard, A. L., Balestrini, J., Booth, A., Bove, P. F., Gui, L., White, E. S., & Niklason, L. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68793 · Cited by 230
Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells
Jacob, A., Vedaie, M., Roberts, D. A., Thomas, D. C., Villacorta-Martin, C., Alysandratos, K.-D., Hawkins, F., & Kotton, D. N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0220-0 · Cited by 211
The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
Abbas, W., Kumar, A., & Herbein, G. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00075 · Cited by 203
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
Rathnasinghe, R., Strohmeier, S., Amanat, F., Gillespie, V. L., Krammer, F., García-Sastre, A., Coughlan, L., Schotsaert, M., & Uccellini, M. B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1838955 · Cited by 197
Self-citationProteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3
Neuman, B. W., Joseph, J. S., Saikatendu, K. S., Serrano, P., Chatterjee, A., Johnson, M. A., Liao, L., Klaus, J. P., Yates, J. R., Wüthrich, K., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02631-07 · Cited by 192
An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening
Amanat, F., White, K. M., Miorin, L., Strohmeier, S., McMahon, M., Meade, P., Liu, W., Albrecht, R. A., Simon, V., Martinez‐Sobrido, L., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.108 · Cited by 182
Self-citationErnst, J. T., Thompson, P. A., Nilewski, C., Sprengeler, P. A., Sperry, S., Packard, G., Michels, T., Xiang, A., Tran, C., Wegerski, C. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00182 · Cited by 150
Li, D., Wei, T., Abbott, C. M., & Harrich, D. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00059-12 · Cited by 141
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection
Heaton, N. S., Moshkina, N., Fenouil, R., Gardner, T. J., Aguirre, S., Shah, P. S., Zhao, N., Manganaro, L., Hultquist, J. F., Noel, J. C., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.017 · Cited by 140
Self-citationCoronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis
Sawicki, S. G., & Sawicki, D. L. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.328-334.1986 · Cited by 126
Aplidin, a Marine Organism–Derived Compound with Potent Antimyeloma Activity In vitro and In vivo
Mitsiades, C. S., Ocio, E. M., Pandiella, A., Maiso, P., Gajate, C., Garayoa, M., Vilanova, D., Montero, J. C., Mitsiades, N., McMullan, C. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5725 · Cited by 112
Self-citationKrastel, P., Roggo, S. P., Schirle, M., Ross, N. T., Perruccio, F., Aspesi, P., Aust, T., Buntin, K., Estoppey, D., Liechty, B., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505069 · Cited by 109
Maroun, J., Bélanger, K., Seymour, L., Matthews, S. W., Roach, J., Dionne, J., Soulières, D., Stewart, D. J., Goel, R., Charpentier, D., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl165 · Cited by 68
Coughlan, L., Bradshaw, A. C., Parker, A. L., Robinson, H. G., White, K. M., Custers, J. H. H. V., Goudsmit, J., van Roijen, N., Barouch, D. H., Nicklin, S. A., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.162 · Cited by 67
Self-citationCoughlan, L., Vallath, S., Saha, A., Flak, M. B., McNeish, I. A., Vassaux, G., Marshall, J. F., Hart, I. R., & Thomas, G. J. (2009) · Journal of Virology · doi:10.1128/jvi.00445-09 · Cited by 62
Self-citationCarelli, J. D., Sethofer, S. G., Smith, G. A., Miller, H., Simard, J. L., Merrick, W. C., Jain, R. K., Ross, N. T., & Taunton, J. (2015) · eLife · doi:10.7554/elife.10222 · Cited by 60
Špıčka, I., Ocio, E. M., Oakervee, H. E., Greil, R., Banh, R. H., Huang, S., D’Rozario, J. M., Dimopoulos, M. A., Martínez, S., Extremera, S., et al. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03739-2 · Cited by 57
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials
Yokoyama, Y., Briasoulis, Α., Takagi, H., & Kuno, T. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198137 · Cited by 45
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variantPreprint
Reuschl, A., Thorne, L., Zuliani‐Alvarez, L., Bouhaddou, M., Obernier, K., Hiatt, J. B., Soucheray, M., Turner, J. L. E., Fabius, J. M., Nguyen, G. T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.24.427991 · Cited by 38
Self-citationWei, T., Li, D., Marcial, D. L., Khan, M., Lin, M., Snape, N., Ghildyal, R., Harrich, D., & Spann, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114447 · Cited by 37
Delgado‐Calle, J., Kurihara, N., Atkinson, E. G., Nelson, J. H., Miyagawa, K., Galmarini, C. M., Roodman, G. D., & Bellido, T. (2019) · Oncotarget · doi:10.18632/oncotarget.26831 · Cited by 37
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjects
Nalda‐Molina, R., Valenzuela, B., Ramón-López, A., Miguel-Lillo, B., Soto-Matos, A., & Ruixo, J. J. P. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0841-4 · Cited by 27
(−)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cells
Ito, M., Itô, J., Kitazawa, H., Shimamura, K., Fukami, T., Tokita, S., Shimokawa, K., Yamada, K., Kanatani, A., & Uemura, D. (2009) · Peptides · doi:10.1016/j.peptides.2009.02.008 · Cited by 25
Morande, P. E., Zanetti, S. R., Borge, M., Nannini, P. R., Jancic, C. C., Bezares, R. F., Bitsmans, A., González, M., Rodríguez, A. L., Galmarini, C. M., et al. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9740-3 · Cited by 24
van den Worm, S. H. E., Knoops, K., Zevenhoven-Dobbe, J. C., Beugeling, C., van der Meer, Y., Mommaas, A. M., & Snijder, E. J. (2011) · Journal of Virology · doi:10.1128/jvi.00403-11 · Cited by 21
Sammaibashi, S., Yamayoshi, S., & Kawaoka, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01446 · Cited by 17
Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis
Soto-Matos, A., Szyldergemajn, S. A., Extremera, S., Miguel-Lillo, B., Alfaro, V., Coronado, C., Lardelli, P., Roy, E., Corrado, C., & Kahatt, C. M. (2011) · Marine Drugs · doi:10.3390/md9061007 · Cited by 15
Cited by
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03995-1 · Cited by 350
Self-citationA Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Forchette, L., Sebastian, W., & Liu, T. (2021) · Current Medical Science · doi:10.1007/s11596-021-2395-1 · Cited by 254
COVID-19 and cellular senescence
Schmitt, C. A., Tchkonia, T., Niedernhofer, L. J., Robbins, P. D., Kirkland, J. L., & Lee, S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00785-2 · Cited by 153
Bioactivity of Marine-Derived Peptides and Proteins: A Review
Shahidi, F., & Saeid, A. (2025) · Marine Drugs · doi:10.3390/md23040157 · Cited by 112
Metadata
- Authors
- White, K. M., Rosales, R., Yildiz, S., Kehrer, T., Miorin, L., Moreno, E., Jangra, S., Uccellini, M. B., Rathnasinghe, R., Coughlan, L., Martinez-Romero, C., Batra, J., Rojc, A., Bouhaddou, M., Fabius, J. M., Obernier, K., Dejosez, M., Guillén, M. J., Losada, A., Avilés, P., Schotsaert, M., Zwaka, T., Vignuzzi, M., Shokat, K. M., Krogan, N. J., & García-Sastre, A.
- Venue
- Science
- Published
- 2021-02-26
- Volume
- 371
- Issue
- 6532
- Pages
- 926-931
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3122927255
- Cited by
- 343
- References
- 57
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.